Shahid Akhter, editor of ETHealthworld, spoke with manish mittalHead of Global Delivery at axtriato learn more about emerging global trends in the digital transformation of healthcare.
What are the emerging global trends in the digital transformation of the pharmaceutical and life sciences industries?
The life sciences industry is in a unique position with tremendous opportunities with vast amounts of data, including prescription data collected by third-party data aggregators from pharmacies and clinical data from systems patient electronics. But this is the only industry where the customer cannot be defined. Typically, a customer buys your product, consumes it, and pays for it. However, no single entity, patient or healthcare provider, makes all of those decisions, making it a complicated and highly competitive industry.
With AI becoming mainstream, computing power and data availability is increasing. To consider rare diseases where the value of each customer is extremely high, but we have yet to determine where the customer will come from. Today we can use analytical models with every patient and doctor in the network and predict where the next patient will emerge. This was not possible three years ago because computing power was not available. With the cloud, we are better positioned to care for patients.
There are some key emerging global trends in the digital transformation of these industries. Firstly, there is an increasing patient-centred approach, with a shift from simply developing and marketing drugs to a more holistic approach, considering the needs/preferences of individual patients. The transition is driven by the increasing availability of patient data, the rise of personalized medicine, and the growing expectation of patients for more personalized care.
Second, a growing trend toward digitization and automation to improve efficiencies, reduce costs, and meet the growing demands of patients and healthcare providers for more accurate and timely information. Automation and digitization also facilitate the development of new products and services, such as personalized medicines, mobile health applications, and remote patient monitoring.
Third, a growing trend toward partnerships between the life sciences industries and other segments, such as the technology, consumer, and healthcare sectors. Many pharmaceutical companies are partnering with technology companies to develop digital health solutions, such as mobile apps, wearables, etc., that help patients manage their health and medication regimens.
Fourth, a growing trend toward sustainability in both industries to address the environmental impact of pharmaceutical production and use, as well as to meet patient and healthcare provider expectations for more sustainable products and practices.
What are the challenges dominating the digital transformation of healthcare?
There are many challenges. First, provide access to quality health services for all patients. Second, to make healthcare more affordable. Third, develop new technologies to improve the quality and efficiency of care through digital. Fourth, create an ecosystem of interoperable health information. Fifth, ensure that patient data is safe and secure. Sixth, determine that IT systems can be scaled to meet the needs of the growing number of patients and providers.
Next and seventh, make sure patients can easily access their data to view and download medical records, schedule appointments, etc.
How does Axtria make a difference?
Axtria was born in 2010 in the US and its operations in India began in 2011. We are transforming healthcare through an AI-powered approach with the most advanced and personalized content and messaging delivery for healthcare businesses. medical. Proven and scalable software helps industry improve patient engagement, grow their business, and shorten the product lifecycle journey before it even hits the market.
New technologies are revolutionizing life sciences with embedded artificial intelligence and advanced analytics deployed at scale. The only way to survive is to put the knowledge into practice faster than the competitors. Axtria Information Management implements a state-of-the-art Big Data framework to rapidly process, govern, and move data into information. Customer sales and digital data is absorbed, processed and consumed in the cloud to help create marketing strategies that can be designed and executed through analytics. A customer’s 360° view influences buying behaviors. With Axtria’s sales IQ life sciences, companies can implement AI-powered segmentation, target list management, and territory alignment for each market.
How do Axtria products help the pharmaceutical and life sciences industries?
Increased automation and the creation of purpose-driven businesses is the new world order. More than ever, companies are looking to replace archaic and ad hoc systems with digital data enablement, analytics at scale, and cloud software to deliver a better customer experience.
At Axtria we support both! We empower global life sciences companies to achieve sustainable growth through digitalization and reinvented innovation. We have emerged as a disruptive and innovative leader with a strong set of AI-powered platforms: Axtria DataMAx™ for data management, Axtria InsightsMAx™ for analytics industrialization, Axtria SalesIQ™ for integrated sales planning and operations, Axtria MarketingIQ™ for decisions marketing key. and Axtria CustomerIQ™ for omnichannel customer engagement.
The products are designed to enable the life sciences industry to achieve its vision of improving patient outcomes. By implementing data and analytics, companies can identify patients more accurately and quickly, helping them reach patients in the right place at the right time with their products.
